Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LDL cholesterol: controversies and future therapeutic directions
Paul M. Ridker
The Lancet (2014) Vol. 384, Iss. 9943, pp. 607-617
Closed Access | Times Cited: 247

Showing 26-50 of 247 citing articles:

Serum Apolipoprotein A-I and Large High-Density Lipoprotein Particles Are Positively Correlated with FEV1 in Atopic Asthma
Amisha V. Barochia, Maryann Kaler, Rosemarie A. Cuento, et al.
American Journal of Respiratory and Critical Care Medicine (2015) Vol. 191, Iss. 9, pp. 990-1000
Open Access | Times Cited: 76
Prevention of cardiovascular disease in rheumatoid arthritis
Ivana Hollan, Patrick H Dessein, Nicoletta Ronda, et al.
Autoimmunity Reviews (2015) Vol. 14, Iss. 10, pp. 952-969
Closed Access | Times Cited: 71
Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps
Thomas Zegkos, George D. Kitas, Theodoros Dimitroulas
Therapeutic Advances in Musculoskeletal Disease (2016) Vol. 8, Iss. 3, pp. 86-101
Open Access | Times Cited: 69
Novel Therapeutical Approaches to Managing Atherosclerotic Risk
Rosaria Vincenza Giglio, Anca Pantea Stoian, Khalid Al‐Rasadi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4633-4633
Open Access | Times Cited: 41
Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis
Jiali Cao, Ziwen Wang, Mengpei Zhu, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials
Paul M. Ridker, Pierre Amarenco, Robert Brunell, et al.
American Heart Journal (2016) Vol. 178, pp. 135-144
Open Access | Times Cited: 60
New Drugs for Treating Dyslipidemia: Beyond Statins
Chang Ho Ahn, Sung Hee Choi
Diabetes & Metabolism Journal (2015) Vol. 39, Iss. 2, pp. 87-87
Open Access | Times Cited: 55
Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation
Sadao Takahashi
Journal of Atherosclerosis and Thrombosis (2017) Vol. 24, Iss. 6, pp. 552-559
Open Access | Times Cited: 55
Serum selenium and lipid levels: Associations observed in the National Health and Nutrition Examination Survey (NHANES) 2011–2012
Krista Christensen, Mark Werner, Kristen Malecki
Environmental Research (2015) Vol. 140, pp. 76-84
Closed Access | Times Cited: 54
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
Cristina Taddei, Rod Jackson, Bin Zhou, et al.
International Journal of Epidemiology (2019) Vol. 49, Iss. 1, pp. 173-192
Open Access | Times Cited: 53
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raisingA systematic review and meta-analysis of relevant preclinical studies and clinical trials
Susan Kühnast, Marta Fiocco, José W.A. van der Hoorn, et al.
European Journal of Pharmacology (2015) Vol. 763, pp. 48-63
Closed Access | Times Cited: 52
Visceral adiposity and metabolic syndrome after very high–fat and low-fat isocaloric diets: a randomized controlled trial
Vivian L. Veum, Johnny Laupsa‐Borge, Øyvin Eng, et al.
American Journal of Clinical Nutrition (2016) Vol. 105, Iss. 1, pp. 85-99
Open Access | Times Cited: 52
An Integrated Lipidomics and Phenotype Study Reveals Protective Effect and Biochemical Mechanism of Traditionally Used Alisma orientale Juzepzuk in Chronic Kidney Disease
Fang Dou, Hua Miao, Jingwen Wang, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 52
Different effects of bariatric surgical procedures on dyslipidemia: a registry-based analysis
Hadar Spivak, Nasser Sakran, Dror Dicker, et al.
Surgery for Obesity and Related Diseases (2017) Vol. 13, Iss. 7, pp. 1189-1194
Closed Access | Times Cited: 49
The protective effects of Chinese yam polysaccharide against obesity-induced insulin resistance
Zhenyong Cheng, Min Hu, Jun Tao, et al.
Journal of Functional Foods (2019) Vol. 55, pp. 238-247
Closed Access | Times Cited: 49
Associations between age and dyslipidemia are differed by education level: The Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort
So Mi Jemma Cho, Ho Jae Lee, Jee‐Seon Shim, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 49
Atherosclerosis and Coronary Artery Disease
Marina Zaromitidou, Gerasimos Siasos, Νικόλαος Παπαγεωργίου, et al.
Elsevier eBooks (2016), pp. 3-24
Closed Access | Times Cited: 48
RECOGNITION AND AVOIDANCE OF ION SOURCE‐GENERATED ARTIFACTS IN LIPIDOMICS ANALYSIS
Changfeng Hu, Wen-Qing Luo, Jie Xu, et al.
Mass Spectrometry Reviews (2020) Vol. 41, Iss. 1, pp. 15-31
Open Access | Times Cited: 46
Protective effect of the new prepared Atractylodes macrocephala Koidz polysaccharide on fatty liver hemorrhagic syndrome in laying hens
YongJun Miao, Xiaoxiao Gao, Danning Xu, et al.
Poultry Science (2020) Vol. 100, Iss. 2, pp. 938-948
Open Access | Times Cited: 44
High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients
Rafael Escate, Teresa Padró, Rosa Suades, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 1, pp. 109-122
Closed Access | Times Cited: 41
Specific recognition, intracellular assay and detoxification of fluorescent curcumin derivative for copper ions
Miao Wang, Ruoqi Zhang, Wim Dehaen, et al.
Journal of Hazardous Materials (2021) Vol. 420, pp. 126490-126490
Closed Access | Times Cited: 33
Tea in cardiovascular health and disease: a critical appraisal of the evidence
Klaus W. Lange
Food Science and Human Wellness (2022) Vol. 11, Iss. 3, pp. 445-454
Open Access | Times Cited: 26
Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom
Misghina Weldegiorgis, Mark Woodward
BMC Nephrology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Low‐density lipoprotein cholesterol and non‐high‐density lipoprotein cholesterol in type 1 diabetes and type 2 diabetes: Lipid goal attainment in a large German–Austrian diabetes registry
Julia Brandts, Sascha R. Tittel, Peter Bramlage, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 12, pp. 3700-3708
Open Access | Times Cited: 14
Dendrobium nobile Lindl. alkaloids improve lipid metabolism by increasing LDL uptake through regulation of the LXRα/IDOL/LDLR pathway and inhibition of PCSK9 expression in HepG2 cells
Jian Sun, H Liu, Mengli Zhang, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 3
Open Access

Scroll to top